TerrAscend Corp (TED) - Net Assets
Based on the latest financial reports, TerrAscend Corp (TED) has net assets worth €95.48 Million EUR (≈ $111.63 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€555.26 Million ≈ $649.16 Million USD) and total liabilities (€459.78 Million ≈ $537.53 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check TED asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €95.48 Million |
| % of Total Assets | 17.2% |
| Annual Growth Rate | 74.24% |
| 5-Year Change | 1490.5% |
| 10-Year Change | N/A |
| Growth Volatility | 1148.28 |
TerrAscend Corp - Net Assets Trend (2016–2024)
This chart illustrates how TerrAscend Corp's net assets have evolved over time, based on quarterly financial data. Also explore TerrAscend Corp (TED) total assets for the complete picture of this company's asset base.
Annual Net Assets for TerrAscend Corp (2016–2024)
The table below shows the annual net assets of TerrAscend Corp from 2016 to 2024. For live valuation and market cap data, see TerrAscend Corp (TED) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €176.82 Million ≈ $206.72 Million |
-26.55% |
| 2023-12-31 | €240.74 Million ≈ $281.45 Million |
-25.04% |
| 2022-12-31 | €321.17 Million ≈ $375.48 Million |
+40.28% |
| 2021-12-31 | €228.95 Million ≈ $267.67 Million |
+1959.49% |
| 2020-12-31 | €11.12 Million ≈ $13.00 Million |
-85.24% |
| 2019-12-31 | €75.33 Million ≈ $88.07 Million |
+30.10% |
| 2018-12-31 | €57.90 Million ≈ $67.69 Million |
-14.05% |
| 2017-12-31 | €67.37 Million ≈ $78.76 Million |
+3137.32% |
| 2016-12-31 | €2.08 Million ≈ $2.43 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to TerrAscend Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 77654818300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €955.47 Million | 539.94% |
| Total Equity | €176.96 Million | 100.00% |
TerrAscend Corp Competitors by Market Cap
The table below lists competitors of TerrAscend Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Orion Gold NL
JSE:ORN
|
$138.53 Million |
|
High Tech Pharm Co. Ltd
KQ:106190
|
$138.56 Million |
|
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd B
SHG:900912
|
$138.59 Million |
|
DEFAMA Deutsche Fachmarkt AG
XETRA:DEF
|
$138.61 Million |
|
Richmond Mutual Bancorporation Inc
NASDAQ:RMBI
|
$138.49 Million |
|
Legacy Education Inc.
NYSE MKT:LGCY
|
$138.49 Million |
|
Singer Thailand Public Company Limited
BK:SINGER
|
$138.46 Million |
|
Origin Property PCL
BK:ORI
|
$138.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in TerrAscend Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 242,496,000 to 176,960,000, a change of -65,536,000 (-27.0%).
- Net loss of 80,232,000 reduced equity.
- Share repurchases of 215,000 reduced equity.
- Other factors increased equity by 14,911,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-80.23 Million | -45.34% |
| Share Repurchases | €215.00K | -0.12% |
| Other Changes | €14.91 Million | +8.43% |
| Total Change | €- | -27.03% |
Book Value vs Market Value Analysis
This analysis compares TerrAscend Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.95x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.81x to 0.95x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €0.71 | €0.58 | x |
| 2018-12-31 | €0.74 | €0.58 | x |
| 2019-12-31 | €0.47 | €0.58 | x |
| 2020-12-31 | €0.01 | €0.58 | x |
| 2021-12-31 | €0.89 | €0.58 | x |
| 2022-12-31 | €1.24 | €0.58 | x |
| 2023-12-31 | €0.84 | €0.58 | x |
| 2024-12-31 | €0.61 | €0.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently TerrAscend Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -45.34%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -26.16%
- • Asset Turnover: 0.51x
- • Equity Multiplier: 3.43x
- Recent ROE (-45.34%) is above the historical average (-1517.75%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -41.67% | 0.00% | 0.00x | 1.86x | €-1.08 Million |
| 2017 | -10.10% | 0.00% | 0.00x | 1.03x | €-13.54 Million |
| 2018 | -39.01% | -322.71% | 0.08x | 1.58x | €-27.68 Million |
| 2019 | -323.62% | -254.26% | 0.18x | 6.91x | €-222.46 Million |
| 2020 | -13068.49% | -78.22% | 0.33x | 508.75x | €-155.24 Million |
| 2021 | 1.39% | 1.48% | 0.36x | 2.60x | €-19.25 Million |
| 2022 | -95.35% | -122.65% | 0.35x | 2.20x | €-335.84 Million |
| 2023 | -37.57% | -28.71% | 0.48x | 2.75x | €-115.35 Million |
| 2024 | -45.34% | -26.16% | 0.51x | 3.43x | €-97.93 Million |
Industry Comparison
This section compares TerrAscend Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $676,868,481
- Average return on equity (ROE) among peers: -100.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| TerrAscend Corp (TED) | €95.48 Million | -41.67% | 4.82x | $138.50 Million |
| Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) | $5.52 Billion | 11.33% | 0.42x | $635.99 Million |
| AYURCANN HOLDINGS CORP. (3ZQ0) | $534.88K | -741.80% | 26.77x | $113.81K |
| LORDS CO. WORLDW. HOLD. (4XM) | $-1.01 Million | 0.00% | 0.00x | $134.78K |
| EQL PHARMA AB (7JK) | $123.63 Million | 25.52% | 0.92x | $148.83 Million |
| Alkermes plc (8AK) | $1.11 Billion | -4.33% | 0.82x | $5.00 Billion |
| OPTIMI HEALTH CORP. (8BN) | $6.57 Million | -56.49% | 1.32x | $17.99 Million |
| LABIANA HEALTH S.A.EO-10 (8RK) | $2.57 Million | 9.87% | 19.25x | $40.60 Million |
| CANNABIS POLAND AB ZY-10 (8TE) | $321.96K | -209.89% | 1.07x | $1.75 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $91.63 Million |
| CRAFTPORT CANNABIS CORP. (BBW0) | $-3.18 Million | 0.00% | 0.00x | $1.45 Million |
About TerrAscend Corp
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, GAGE Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, Cookies, and Lemonnade. The company also operat… Read more